The hottest Pharma Substack posts right now

And their main takeaways
Category
Top Technology Topics
The Dossier β€’ 290 implied HN points β€’ 12 Mar 24
  1. Martin Kulldorff was fired from the CDC committee for promoting a non-mRNA vaccine and disagreeing with the decision to pause the Johnson & Johnson Covid vaccine.
  2. Kulldorff's experience highlights the powerful influence of the Pharma-Government Health system in America.
  3. Kulldorff's stance against vaccine mandates and his opposition to Pharma influence showcases his courage and bravery in the scientific community.
uTobian β€’ 8195 implied HN points β€’ 14 Apr 23
  1. Psychopaths who fit in are more dangerous than the stereotypical crazy ones because they are harder to spot.
  2. The American public health establishment includes individuals who seem well-adjusted but are responsible for significant harm, like downplaying vaccine safety concerns.
  3. The public health system is run by individuals who are well-adjusted to an insane society, perpetuating harm while appearing normal.
The DisInformation Chronicle β€’ 665 implied HN points β€’ 07 Mar 23
  1. Pandemic reporting should prioritize seeking facts over favoring biopharma public relations.
  2. Journalists should uphold journalistic ethics and verify claims before publishing articles.
  3. Advocacy journalism threatens democracy by undermining informed decision-making and should be countered with fact-based reporting.
Fifty Years News β€’ 38 implied HN points β€’ 25 Sep 23
  1. Preventing hallucinations and improving AI efficiency is important in AI development.
  2. Elicit has the potential to generate substantial revenue by assisting various industries in speeding up research processes.
  3. Elicit's systematic and transparent approach to research aims to have a significant positive impact on society by accelerating scientific discovery.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
Discharge Summary β€’ 0 implied HN points β€’ 28 Mar 23
  1. Pharma companies like Eli Lilly, Novo Nordisk, and Sanofi are reducing insulin prices, capping payments, and making insulin more affordable.
  2. Advocacy efforts from patients and community members played a significant role in influencing legislation that led to these pricing changes.
  3. Legislation such as the Inflation Reduction Act and the American Rescue Plan impacted the insulin market, pushing pharma companies to lower prices to avoid significant financial penalties.